Novel Strategies to Prevent Catheter-Associated Infections in Oncology Patients

References

• Jarvis WR, Edwards JR, Culver DH et al. Nosocomial infection rates in adult and paediatric intensive care units in the United States. Am J Med 1991; 91: 1855–915.
   Google Scholar
• Maki DG. Nosocomial bacteremia. A epidemiological overview. Am J Med 1981; 70: 719–32.
   PubMed Web of Science ®Google Scholar
• Maki DG. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Bisno AL, Waldvogel FA, eds. Infections associat-ed with indwelling medical devices. Washington, DC: American Society of Microbiology. 1989: 161-77.
   Google Scholar
• Moro ML, Vigano EF, Cozzi Lepri A. Risk factors for central venous catheter-related infections in surgical and inten-sive care units. The central venous catheter-related infections study group. Inf Contr Hosp Ep 1994; 15: 253–64.
   PubMed Web of Science ®Google Scholar
• Nystrom B. Bacteraemia in surgical patients with intra-venous devices: a European multicenter incidence study. Hosp Infect 1983; 4: 338–49.
   Web of Science ®Google Scholar
• Oakes JA, Wood AJJ. Infections in surgery. N Engl J 1986; 315: 1129–38.
   PubMed Web of Science ®Google Scholar
• Nelson CL. Environmental bacteriology in the unidirec-tional (horizontal) operating room. Arch Surg 1979; 114: 778–82.
   PubMed Web of Science ®Google Scholar
• Pittet D, Wenzel RP. Nosocomial bloodstream infections in the critically III. JAMA 1994; 272/23: 1819–20.
   Web of Science ®Google Scholar
• Viot M. Intravenous access: related problems in oncolo-gy. Int J Antimicrob Agents 2000; 16 (2): 165–8.
   PubMed Web of Science ®Google Scholar
• Henrickson KJ, Axtell RA, Hoover SM, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ ciprofloxacin/ heparin flush solution: A ran-domized, multicenter, double-blind trial. J Clin Oncol 2000; 18 (6): 1269–78.
   PubMed Web of Science ®Google Scholar
• Kaplan SS, Basfort RE, Kormos RL. Biomaterial-associ-ated impairment of local neutrophil function. Am Soc Artif Organs J 1990; 36: M172–75.
   Google Scholar
• Noble MA, Grant SK, Hajen E. Characterization of a neutrophil-nhibitor factor from clinically significant S. epider-midis infection. J Inf Dis 1990; 162: 909–13.
   PubMed Web of Science ®Google Scholar
• Garrison JR, Brittian KR, Lam TM, Peyton JC, Bergamini TM. MHC II: Expression is decreased in S. epider-midis graft infection. Presented at The Society of University Surgeons, Thirty-seventh Annual University Surgical Resident's Conferences. Denver, Colorado: 1995.
   Google Scholar
• Henke PK, Bergamini TM, Brittian KR, Polk HCJr. Prostaglandin E2 modulates monocyte MHC-II (Ia) suppression in biomaterial infection. J Surg Res 1997; 69 (2): 372–8.
   PubMed Web of Science ®Google Scholar
• Henke PK, Bergamini TM, Garrison JR, Brittian KR, Peyton JC, Lam TM. Staphylococcus epidermidis graft infec-tion is associated with locally suppressed major histocompati-bility complex class II and elevated MAC-1 expression. Arch Surg 1997; 132 (8): 894–902.
   PubMedGoogle Scholar
• Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infections: evidence for a local granulocyte defect. J Clin Invest 1984; 73: 1191–200.
   PubMed Web of Science ®Google Scholar
• Shanbhag A, Yang J, Lilien J, Black J. Decreased neu-trophil respiratory burst on exposure to cobaltchrome alloy and polystyrene in vitro. J Biomed Mat Res 1992; 26: 185–95.
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Waldvogel A, Vaudaux P et al. Pathogenesis of foreign body infections: description and char-acteristics of an animal model. J Infect Dis 1982; 146: 487–97.
   Google Scholar
• Modun B, Williams P, Pike WJ. Cell envelope proteins of S.epidermidis grown in vivo in a peritoneal chamber implant. Infect Immun 1992; 60: 2551–3.
   PubMed Web of Science ®Google Scholar
• Henke PK, Bergamini TM, Watson AL, Brittian KR, Powell DW, Peyton JC. Bacterial products primarily mediate fibroblast inhibition in biomaterial infection. J Surg Res 1998; 74 (1): 17–22.
   PubMed Web of Science ®Google Scholar
• Sapatnekar S, Kao WJ, Anderson JM. Leukocyte-bio-material interactions in the presence of Staphylococcus epi-dermidis: flow cytometric evaluation of leukocyte activation. J Biomed Mater Res 1997; 35 (4): 409–20.
   PubMed Web of Science ®Google Scholar
• Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995; 16 (8): 451–8.
   PubMed Web of Science ®Google Scholar
• Bergamini TM, Corpus RA, McCurry TM, Peyton JC, Brittian KR, Cheadle WC. Immunosuppression augments growth of adherent Staphylococcus epidermidis. Arch Surg 1995; 130: 1345–50.
   PubMedGoogle Scholar
• Salzmann MB, Rubin LG. Advances in Pediatric Infectious Diseases. Mosby Year Book Inc 1995; 10: 267–88.
   Google Scholar
• Widmer AF. Prevention and control of nosocomial infections. In: Wenzel RP, ed. Baltimore, Maryland: Williams & Wilkins. 1993: 556-79.
   Google Scholar
• Sherertz RJ, Raad II, Belani A, et al. Three-year expe-rience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990; 28 (1): 76–82.
   PubMed Web of Science ®Google Scholar
• Sitges-Serra A, Linares J. Limitations of semiquantita-live method for catheter culture. J Clin Microbiol 1988; 26 (5): 1074–6.
   PubMed Web of Science ®Google Scholar
• Collignon PJ, Soni N, Pearson IY, Woods WP, Munro R, Sorrell TC. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bac-teremia? J Clin Microbiol 1986; 24 (4): 532–5.
   PubMed Web of Science ®Google Scholar
• Armstrong CW, Mayhall CG, Miller KB, et al. Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol 1990; 11 (2): 71–8.
   PubMed Web of Science ®Google Scholar
• Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheter-related bac-teremia. Pediatr Infect Dis J 1987; 6 (8): 729–34.
   PubMed Web of Science ®Google Scholar
• Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997; 35 (3): 641–6.
   PubMed Web of Science ®Google Scholar
• Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993; 153 (15): 1791–6.
   Google Scholar
• Bertoglio S, Meszsaros P, Disomma C, et al. Long-term central venous access in oncology. Review of a caseload of 750 cases. Minerva Chir 1996; 51 (6): 427-31.
   Google Scholar
• Lyon RD, Griggs KA, Johnson AM, Olsen JR. Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol 1999; 10 (4): 463–71.
   PubMed Web of Science ®Google Scholar
• Kohnen W. Novel antiinfective biomaterials by polymer modification. In: Charles G, eds. Biotechnology and bioactive Polymers. Plenum Press 1996: 317-26.
   Google Scholar
• Dumitriu S, Popa MI, Haulacia I, Cringu A, Stratone A. Bioactive polymers 61. synthesis and characterization of some retard antibiotics. Colloid Polym Sci 1989; 267: 595–9.
   Google Scholar
• Simionescu CI, Dumitriu S, Popa MI, Denisova L. Antibiotics immobilized on polysaccharides. Makromol Chem Suppl 1985; 9: 179–87.
   Google Scholar
• Solovskij MV, Ulbrich K, Kopecek J. Synthesis of N-(2-hydroxypropyl) methacrylamide copolymers with antimicrobial activity. Biomat 1983; 4: 44.
   PubMed Web of Science ®Google Scholar
• Williams RL, Doherty PJ, Vince DG et al. The biocom-patibility of silver. Crit Rev Biocomp 1989; 5: 221–43.
   Web of Science ®Google Scholar
• The pharmacological basis of therapeutics. 7th ed. Macmillan Publishing Company, New York, Collier Macmillan Canada, Inc., Toronto, Collier Macmillan Publishers, London: Goodman and Gilman's. 1985: 963-7.
   Google Scholar
• Becker RO, Spadaro JA. Treatment of orthopedic infections with electrically generated silver ions. J Bone Jt Surg 1978; 60(A): 871-88.
   Google Scholar
• Benvenisty Al, Tannenbaum G, Alhorn TN, et al. Control of prosthetic bacterial infection: evaluation of an easi-ly incorporated, tightly bound, silver antibiotic PETE graft. J Surg Res 1988; 44: 1–2.
   PubMed Web of Science ®Google Scholar
• Colmano G, Edwards SS, Barranco SD. Activation of antibacterial silver coatings on surgical implants by direct cur-rent: preliminary studies in rabbits. Am J Vet Res 1980; 41: 964–6.
   PubMed Web of Science ®Google Scholar
• Chu CC, Tsai WC, Yao JY, Chiu SS. Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study. J Biomed Mater Res 1987; 21: 1281–1300.
   PubMed Web of Science ®Google Scholar
• Deitch EA, Marino AA, Gillespie TE, Albright JA. Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother 1983; 23: 356–9.
   PubMed Web of Science ®Google Scholar
• Falone AE, Spadaro JA. Inhibitory effects of electrically activated silver material on cutaneous wound bacteria. Plast Reconstruc Surg 1986; 77: 455–9.
   PubMed Web of Science ®Google Scholar
• Furr JR, Russell AD, Turner TD, Andrews A. Antibacterial activity of actisorb plus, Actisorb and silver nitrate. J Hosp Inf 1994; 27: 201–8.
   PubMed Web of Science ®Google Scholar
• Schaeffer AJ, Story KO, Johnson SM. Effect of silver oxide/trichloroisocyanuric acid antimicrobial urinary drainage system on catheter-associated bacteriuria. J Urol 1988; 139: 69–73.
   PubMed Web of Science ®Google Scholar
• Tsai WC, Chu CC, Chin SS, Yao JY. In vitro quantita-tive study of newly made antibacterial braided nylon sutures. Surg Gynecol Obstet 1987; 165: 207–11.
   PubMedGoogle Scholar
• Spadaro JA, Chase SE, Webster DA. Bacterial inhibi-tion by electrical activation of percutaneous silver implants. J Biomed Mater Res 1986; 20: 565–77.
   PubMed Web of Science ®Google Scholar
• Bambauer R, Mestres P, Schiel R, Sioshansi P. New surface-treatment technologies for catheters used for extracor-poreal detoxification methods. Dial Transpl 1995; 24 (5): 228–37.
   Google Scholar
• Bambauer R, Schiel R, Mestres P, Sioshansi P. Scanning electron microscopic investigations of surface treated large-bore catheters used for extracorporeal detoxification methods. Int J Art Org 1995; 18 (5): 326–31.
   PubMed Web of Science ®Google Scholar
• Sioshansi P. New processes for surface treatment of catheters. Art Org 1994; 18 (4): 266–71.
   PubMed Web of Science ®Google Scholar
• Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriaemia. Br J Urol 1990; 65: 379–81.
   PubMedGoogle Scholar
• McLean RJC, Hussain AA, Sayer M, Vincent PJ, Hughes DJ, Smith TJN. Antibacterial activity of multilayer sil-ver-copper surface film on catheter material. Can J Microbiol 1993; 39: 895–9.
   PubMed Web of Science ®Google Scholar
• Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for pre-vention of infection with central venous catheters: a prospec-tive randomized multicenter trial. JAMA 1988; 85: 307–16.
   PubMed Web of Science ®Google Scholar
• Babycos CR, Barrocas A, Webb WR. A prospective randomized trial comparing the silver-impregnated collagen cuff with the bedside turned subclavian catheter. Par Nutr 1993; 17/1: 61–3.
   Web of Science ®Google Scholar
• Flowers R, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989; 261: 878–83.
   PubMed Web of Science ®Google Scholar
• Girvent M. Failure of silver impregnated subcutaneous cuffs to prevent intravascular catheter infection. Am Surg 1995; 221: 115–6.
   Google Scholar
• Dahlberg PJ, Agger WA, Singer JR, et al. Subclavian haemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Contr Hosp Epidemiol 1995; 16: 506–11.
   PubMed Web of Science ®Google Scholar
• Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. JAMA 1995; 98: 349–58.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Beuth J, Pulverer G. Silver coating of medical devices for catheter-associated infections? Am J Med 1999; 107 (1): 101–2.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Lucas L, Pulverer G. Silver coating of medical devices-A review. J Hosp Inf 1998; 40: 257–62.
   PubMed Web of Science ®Google Scholar
• Rungby J, Hultman P, Ellermann-Eriksen S. Silver affects viability and structure of cultured mouse peritoneal macrophages and perioxidative capacity of whole mouse liver. Arch Toxicol 1987; 59: 408–12.
   PubMed Web of Science ®Google Scholar
• Rungby J. An experimental study on silver in the ner-vous system and on aspects of its general cellular toxicity. Dan Med Bull 1987; 37 (5): 442–9.
   Google Scholar
• Rungby J. Experimental argyrosis: ultrastructural local-ization of silver in rat eye. Exp Mol Path 1986; 45: 22–30.
   PubMed Web of Science ®Google Scholar
• Rungby J, Ellermann-Eriksen S, Danscher G. Effects of selenium on toxicity and ultrastructural localization of silver in cultured macrophages. Arch Toxicol 1987; 61: 40–5.
   PubMed Web of Science ®Google Scholar
• Sudmann E, Vik H, Rait M, Todnem K, Andersen KJ, Julsham K. Muscle paralysis in a patient with total hip pros-thesis and silver-impregnated antibacterial bone cement. Act Orth Scand 1985; 56: 534.
   Google Scholar
• Jansen B, Jansen S, Peters G, Pulverer G. In-vitro effi-cacy of a central venous catheter (“Hydrocath”) loaded with teicoplanin to prevent bacterial colonization. Hosp Inf 1992; 22: 93–107.
   PubMed Web of Science ®Google Scholar
• Jansen B, Kristinsson KG, Jansen S, Peters G, Pulverer G. In-vitro efficacy of a central venous catheter complexed with iodine to prevent bacterial colonization. Antimicrob Chem 1992; 30: 135–9.
   PubMed Web of Science ®Google Scholar
• Tebbs SE, Elliott TSJ. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J Antimicrob Chemother 1993; 31: 261–71.
   PubMed Web of Science ®Google Scholar
• Tebbs SE, Elliott TSJ. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis 1994; 13: 111–7.
   PubMed Web of Science ®Google Scholar
• Kamal GD, Pfaller MA, Rempe LE, Jebson RJR. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364–8.
   Google Scholar
• Nosher JL, Ericksen AS, Trooskin SZ, Needell GS, Harvey RA, Greco RS. Antibiotic bonded nephrostomy catheters for percutaneous nephrostomies. Cardiovasc Int Rad 1990; 13 (2): 102–6.
   PubMed Web of Science ®Google Scholar
• Trooskin SZ, Harvey RA, Lennard TW, Greco RS. Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters. Periton Dial Int 1990; 10 (1): 57–9.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. Inf Dis 1993; 167: 920–2.
   PubMed Web of Science ®Google Scholar
• Sampath LA, Chowdhury N, Caraos L, Modak SM. Infection resistance of surface modified catheters with either short-lived or prolonged activity. J Hosp Infect 1995; 30: 201–10.
   PubMed Web of Science ®Google Scholar
• Bach A, Bottiger B, Böhrer H, Motsch J, Martin E. Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Int Care Med 1996; 22: 1066–9.
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Robert J, Beauchamp D. Pharmacodynamics of antibiotics in fibrin clots. J Antimicrob Chemother 1993; 31 Suppl. D: 113.
   Google Scholar
• Gutschik E. The enterococcus endocarditis model in experimental animals and its relevance to human infection. J Antimicrob Chemother 1993; 31 Suppl. D: 87.
   Google Scholar
• Barza M. Pharmacokinetics of antibiotics in shallow and deep compartments. J Antimicrob Chemother 1993; 31 Suppl. D: 17.
   Google Scholar
• Olanoff LS, Anderson JM, Jones RD. Sustained release of gentamicin from prosthetic heart valves. Trans Am Soc Artif Intern Organs 1979; 25: 334–8.
   PubMedGoogle Scholar
• Kingston D, Birnie EDC, Martin J, Pearce PC, Manek S, Quinn CM. Experimental pathology of intravenous polyurethane cannulae containing disinfectant. J Hosp Infect 1992; 20: 257–70.
   PubMed Web of Science ®Google Scholar
• Kingston D, Hill ID. Elution of disinfectant from polyurethane cannula tubing. J Hosp Inf. 1990; 16: 271–80.
   PubMed Web of Science ®Google Scholar
• Seal DV, Barrett SP. The development of irgasan-impregnated intravenous cannulae. In: Wadstrom J, Eliasson I, Holder I, Ljungh A, eds. Pathogenesis of wound and biomate-rial-associated infections. London, Berlin, Heidelberg, New York: Springer 1990: 501-506.
   Google Scholar
• Solomon DD, Sherertz RJ. Antibiotic releasing poly-mers. J Contr Rel 1987: 343–52.
   Google Scholar
• Schierholz JM, Rump AFE, Pulverer G. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections. Drug Res 1997; 47 (1) 1: 70-74.
   Google Scholar
• Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in pre-venting subcutaneous staphylococcus aureus infection in rab-bits. J Inf Dis 1993; 167: 98–106.
   PubMed Web of Science ®Google Scholar
• Sherertz RJ, Forman DM, Solomon DD. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcu-taneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 1989; 33 (8): 1174–8.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Jansen B, Steinhauser H, Peters G, Schuhmacher-Perdreau F, Pulverer G. Drug release from antibiotic-containing polyurethanes. New Polymeric Mater 1990; 3: 61–72.
   Google Scholar
• Schierholz JM, Steinhauser H, Rump AFE, Berkels R, Pulverer G. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomat 1997; 18: 257–8.
   PubMed Web of Science ®Google Scholar
• Hampl J, Schierholz J, Jansen B, Aschoff A. In vitro and in vivo efficacy of rifampin loaded silicone catheter in pre-vention of CSF-shunt infections. Acta Neurochirurg 1995; 133: 147–52.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Jansen B, Jaenicke L, Pulverer G. In vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomat 1994; 15: 996–1000.
   PubMed Web of Science ®Google Scholar
• Schierholz JM, Pulverer G. Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zbl Bakt 1997; 286 (1): 107–23.
   PubMedGoogle Scholar
• Schierholz JM, Pulverer G. Investigation of a rifampin, fusidic-acid and mupirocin releasing silicone catheter. Biomat 1998; 19: 2065–74.
   PubMed Web of Science ®Google Scholar
• Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995; 39: 2397–400.
   PubMed Web of Science ®Google Scholar
• Raad I, Darouiche R. Central venous catheters (CVC) coated with minocycline and rifampicin (m/r) for the preven-tion of catheter-related bacteremia (CRB). Am Soc Microbiol 1995: 258.
   Google Scholar
• Bach A, Böhrer H, Motsch J, Martin E, Geiss HK, Sonntag HG. Prevention of bacterial colonization of intra-venous catheters by antiseptic impregnation of polyurethane polymers. Antimicrob Agents Chemother 1994; 33: 969–78.
   Web of Science ®Google Scholar
• Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A ran-domized, controlled trial. Ann Int Med 1997; 127 (4): 257–66.
   PubMed Web of Science ®Google Scholar
• Civetta JM, Hudson-Civetta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 1996; 24: 10.
   PubMed Web of Science ®Google Scholar
• Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996; 37 (2): 315–22.
   PubMed Web of Science ®Google Scholar
• Heard SO, Wagle M, Vijayakumar E, Doern G. The influence of triple-lumen central venous catheters coated with chlorhexidine/silver sulfadiazine on the incidence of catheter-related bacteraemia. Arch Intern Med 1998; 158: 81–7.
   PubMed Web of Science ®Google Scholar
• Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter related infection and sepsis. Am Surg 1996; 62: 641–5.
   PubMed Web of Science ®Google Scholar
• Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurh E. No difference in catheter sepsis between stan-dard and antiseptic central venous catheters. Arch Surg 1996; 131: 986.
   PubMed Web of Science ®Google Scholar
• Ellis ME, Rhydderch D, Zwaan F, Guy ML, Baillie F. High incidence of line-related infection and mechanical failure of an antiseptic impregnated central venous catheter in highly immunocompromised patients. Scand J Infect Dis 1996; 28: 91–3.
   PubMed Web of Science ®Google Scholar
• Logghe C, Van Ossel Ch, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the pre-vention of bloodstream infection in leukaemic patients: a ran-domized controlled trial. J Hosp Inf 1997; 37: 145–56.
   PubMed Web of Science ®Google Scholar
• Veenstra DL, Saint S, Somnath S, Lumley T, Sullivan SD. Efficacy of antiseptic impregnated central venous catheters in preventing catheter-related bloodstream infections. JAMA 1999; 281 (3): 261–7.
   PubMed Web of Science ®Google Scholar
• Yticel N, Max M, Rossaint R, et al. Central venous catheters coated with miconazole and rifampin for the preven-tion of catheter-related colonization and bloodstream infec-tions. Results of the pilot part of an ongoing clinical trial. Langenbecks Arch Surg 2001; 386: A70.
   Google Scholar